https://www.biopharmadive.com/news/pfizer-duchenne-gene-therapy-phase-3-sarepta/592936/
Pfizer beats Sarepta to start of first late-stage Duchenne gene therapy trial | BioPharma Dive
late stage duchennepfizer
https://www.streetwisereports.com/article/2025/10/01/biotech-secures-fda-alignment-on-late-stage-duchenne-therapy.html?m_t=2025_10_01_07_27_12
Biotech Secures FDA Alignment on Late-Stage Duchenne Therapy
Capricor Therapeutics Inc. (CAPR:NASDAQ) reached agreement with the FDA to include HOPE-3 trial data in its BLA for Deramiocel, its cell therapy for Duchenne...
late stage duchennebiotechfda